E-scape Bio's Series A Round

E-scape Bio raised a round of funding on August 31, 2015.

E-scape is developing therapeutics against genetic targets for neurodegenerative disease including Alzheimer's Disease and Lewy Body Disease. E-scape's small molecule approach binds to mutated protein…

Articles about E-scape Bio's Series A Round: